Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection-Reference-Cited by-同舟云学术

Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection

Published:2006-11-14 Issue:17 Volume:20 Page:2175-2181
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Lissen Eduardo,Clumeck Nathan,Sola Ricardo,Mendes-Correa Maria,Montaner Julio,Nelson Mark,DePamphilis Jean,Pessôa Mário,Buggisch Peter,Main Janice,Dieterich Douglas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference14 articles.

1. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis N and C in HIV co-infected patients;Alberti;J Hepatol,2005

2. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy;Brau;AIDS,2003

3. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group;Benhamou;Hepatology,1999

4. A comparison of fibrosis progression in chronic liver diseases;Poynard;J Hepatol,2003

5. Diagnosis, management, and treatment of hepatitis C;Strader;Hepatology,2004

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysis;Meta Gene;2021-09

2. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease;Alimentary Pharmacology & Therapeutics;2016-11-07

3. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection;Journal of Medical Virology;2016-07-27

4. Natural history of liver disease and effect of hepatitis C virus on HIV disease progression;Current Opinion in HIV and AIDS;2015-09

5. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection;Expert Opinion on Drug Safety;2015-03-26